43 results on '"Belshe, Robert B."'
Search Results
2. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine
3. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
4. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations
5. Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50) in healthy vaccinia-naïve individuals
6. Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario
7. An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humans
8. The need for quadrivalent vaccine against seasonal influenza
9. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
10. Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine
11. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
12. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity
13. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
14. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States
15. Clinical and immunologic responses to multiple doses of IMVAMUNE ® (Modified Vaccinia Ankara) followed by Dryvax ® challenge
16. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines
17. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
18. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3 cp45) among susceptible infants and toddlers
19. Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection
20. Current status of live attenuated influenza virus vaccine in the US
21. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent
22. Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1 SF-2 recombinant GP120
23. Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus
24. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control
25. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
26. Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies
27. Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
28. 50 - Herpes simplex virus vaccines
29. Chapter 16 - Influenza vaccine-live
30. List of Contributors
31. Contributors
32. Letter to the Editor
33. Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160
34. Modulation of immunologic responses to HIV-1 MN recombinant gp160 vaccine by dose and schedule of administration
35. HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva
36. Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein
37. Cold-passaged human parainfluenza type 3 viruses contain ts and non- ts mutations leading to attenuation in rhesus monkeys
38. A Review of Adenoviruses in the Etiology of Acute Hemorrhagic Cystitis
39. Superiority of Live Attenuated Compared with Inactivated Influenza A Virus Vaccines in Older, Chronically III Adults
40. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins
41. Acellular pertussis vaccines in infants: evaluation of single component and two-component products
42. 24 - Parainfluenza Virus Vaccines
43. Influenza as a zoonosis: how likely is a pandemic?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.